Quinolone Antibiotics Induce Shiga Toxin–Encoding Bacteriophages, Toxin Production, and Death in Mice
Citations Over TimeTop 1% of 2000 papers
Abstract
Shiga toxin-producing Escherichia coli (STEC) cause significant disease; treatment is supportive and antibiotic use is controversial. Ciprofloxacin but not fosfomycin causes Shiga toxin-encoding bacteriophage induction and enhanced Shiga toxin (Stx) production from E. coli O157:H7 in vitro. The potential clinical relevance of this was examined in mice colonized with E. coli O157:H7 and given either ciprofloxacin or fosfomycin. Both antibiotics caused a reduction in fecal STEC. However, animals treated with ciprofloxacin had a marked increase in free fecal Stx, associated with death in two-thirds of the mice, whereas fosfomycin did not. Experiments that used a kanamycin-marked Stx2 prophage demonstrated that ciprofloxacin, but not fosfomycin, caused enhanced intraintestinal transfer of Stx2 prophage from one E. coli to another. These observations suggest that treatment of human STEC infection with bacteriophage-inducing antibiotics, such as fluoroquinolones, may have significant adverse clinical consequences and that fluoroquinolone antibiotics may enhance the movement of virulence factors in vivo.
Related Papers
- → Human Neutrophils and Their Products Induce Shiga Toxin Production by Enterohemorrhagic Escherichia coli(2001)136 cited
- → Oxidative Stress in Shiga Toxin Production by Enterohemorrhagic Escherichia coli(2015)44 cited
- → Mechanisms that Determine the Differential Stability of Stx+ and Stx− Lysogens(2016)21 cited
- → High-Throughput Method for Rapid Induction of Prophages from Lysogens and Its Application in the Study of Shiga Toxin-Encoding Escherichia coli Strains(2010)28 cited
- → Evolution of the Stx2-Encoding Prophage in Persistent Bovine Escherichia coli O157:H7 Strains(2012)25 cited